Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 25 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PHARMALLIANCE from Lasne, company number BE0867465852, closed financial year 2025 with a result of € 43,298 after tax. For that financial year PHARMALLIANCE recorded a gross margin of € 1.2 million and equity of € 1.2 million. Compared with financial year 2024, the result moved from € 62,582 to € 43,298. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 22, 2026.
€ 1.2 million
▲ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 43,298
▼ 31% vs 2024
Profit after tax over the fiscal year.
€ 68,305
▼ 47% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1.2 million.
People and assets in 2025
13.5
▲ 0.8 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 790,856
▲ 36% vs 2024
€ 58,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 59,540
▼ 26% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 2.4 million
▼ 15% vs 2024
€ 521,552 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 1.9 million
▲ 1% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 124,868
▼ 11% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 944,428 | € 989,844 | € 886,497 | € 1,219,531 | ▲ 38% |
| Profit after taxes | € 201,094 | € 207,403 | € 62,582 | € 43,298 | ▼ 31% |
| Equity | € 996,401 | € 1,143,804 | € 1,206,386 | € 1,249,684 | ▲ 4% |
| Total debts | € 3,125,312 | € 5,163,446 | € 5,276,329 | € 5,130,233 | ▼ 3% |
| Cash | € 113,294 | € 116,107 | € 127,884 | € 68,305 | ▼ 47% |
| Land & buildings | € 134,213 | € 1,484,394 | € 1,502,610 | € 1,446,898 | ▼ 4% |
| Retained profit | € 934,901 | € 1,082,304 | € 1,144,886 | € 1,188,184 | ▲ 4% |
| Dividend | € 60,000 | € 60,000 | € 0 | € 0 | |
| Bank debt | € 1,040,115 | € 2,426,244 | € 2,817,968 | € 2,392,887 | ▼ 15% |
| Balance sheet total | € 4,121,713 | € 6,307,250 | € 6,482,715 | € 6,379,917 | ▼ 2% |
| Employees (FTE) | 9.6 | 11.1 | 12.7 | 13.5 | ▲ 0.8 |
Key figures of PHARMALLIANCE, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMALLIANCE?
What happened at PHARMALLIANCE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- BLUESTONE SRL stepped down as director. NBB
- JEAN-CLAUDE MAHIEU stepped down as director. NBB
- LENANS SA stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 43,298 (▼ 31% vs 2024). filed late Source: NBB ↗
- New establishment in Tournai. KBO
- BLUESTONE SRL became a director. NBB
- JEAN-CLAUDE MAHIEU became a director. NBB
- LENANS SA became a director. NBB
In short
From € 201,094 profit in 2023 to € 43,298 profit in 2025.
Paid € 158,826 in corporate taxes since 2023.
Best year ever: 2024, with € 207,403 profit.
On average € 90,300 of value added per employee in 2025.
A new publication or filing at PHARMALLIANCE? We notify you, reason included.
Follow PHARMALLIANCEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of LENANS, BLUESTONE, SWAKOPMUND, Société de Participations et de Gestion Financières et Immobilières comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMALLIANCEThe shares are held by LENANS (40%), BLUESTONE (18%), SWAKOPMUND (18%) and Société de Participations et de Gestion Financières et Immobilières (8%).
Directors
According to the 2025 annual accounts
Managing director · represented by RANSART PAUL
Also active at: COMPAGNIE FINANCIERE ET IMMOBILIERE DE LA DYLE, PHARMACIE de BARRY, PALATINE, LENANS, IMMOLENANS, ANCIAUX, DIGITALE, DELTAPHAR +6 more
since 2016 · until 2029
JEAN-CLAUDE MAHIEU
Director
since 2016 · until 2029
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue de la Bachée 84
1380 Lasne
Herdersstaflaan 78
1160 Oudergem
Active since 24 September 2004
Rue Colonel Aviateur Daumerie(B) 12
7940 Brugelette
Active since 1 January 2006
Chaussée du Roi Baudouin 192 box a
7030 Mons
Active since 1 March 2016
Chaussée de Mons(BAR) 21 box B
7534 Tournai
Active since 1 February 2024
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0867.465.852
- VAT number
- BE 0867.465.852
- Registered office
- Rue de la Bachée 84, 1380 Lasne
- Names & denominations
- PHARMALLIANCE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 28 September 2004
- Peppol
- Active · Active since 24 Nov 2023
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten